117 related articles for article (PubMed ID: 1437291)
1. Acceptance of class II major histocompatibility complex disparate skin grafts associated with suppressor cells and elevated Langerhans cell numbers.
Odling KA; Halliday GM; Muller HK
Pathology; 1992 Jul; 24(3):184-9. PubMed ID: 1437291
[TBL] [Abstract][Full Text] [Related]
2. Enhanced survival of skin grafts depleted of Langerhans' cells by treatment with dimethylbenzanthracene.
Odling KA; Halliday GM; Muller HK
Immunology; 1987 Nov; 62(3):379-85. PubMed ID: 3117676
[TBL] [Abstract][Full Text] [Related]
3. Effects of gliotoxin on Langerhans' cell function: contact hypersensitivity responses and skin graft survival.
McMinn PC; Halliday GM; Muller HK
Immunology; 1990 Sep; 71(1):46-51. PubMed ID: 1698716
[TBL] [Abstract][Full Text] [Related]
4. Carcinogen-treated skin allografts rejected by T lymphocytes specific for class I but not class II MHC antigens.
Halliday GM; Odling KA; Muller HK
Cell Immunol; 1993 Oct; 151(2):291-9. PubMed ID: 8402936
[TBL] [Abstract][Full Text] [Related]
5. Interferon-gamma is necessary for initiating the acute rejection of major histocompatibility complex class II-disparate skin allografts.
Ring GH; Saleem S; Dai Z; Hassan AT; Konieczny BT; Baddoura FK; Lakkis FG
Transplantation; 1999 May; 67(10):1362-5. PubMed ID: 10360591
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of benzo[a]pyrene and dimethylbenz[a]-anthracene on Langerhans cell distribution and contact sensitization in murine epidermis.
Ruby JC; Halliday GM; Muller HK
J Invest Dermatol; 1989 Feb; 92(2):150-5. PubMed ID: 2493054
[TBL] [Abstract][Full Text] [Related]
7. Indomethacin inhibits the chemical carcinogen benzo(a)pyrene but not dimethylbenz(a)anthracene from altering Langerhans cell distribution and morphology.
Andrews FJ; Halliday GM; Narkowicz CK; Muller HK
Br J Dermatol; 1991 Jan; 124(1):29-36. PubMed ID: 1899617
[TBL] [Abstract][Full Text] [Related]
8. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.
Peeler JS; Niederkorn JY
J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767
[TBL] [Abstract][Full Text] [Related]
9. Adoptively transferred CD4+ lymphocytes from CD8 -/- mice are sufficient to mediate the rejection of MHC class II or class I disparate skin grafts.
Dalloul AH; Chmouzis E; Ngo K; Fung-Leung WP
J Immunol; 1996 Jun; 156(11):4114-9. PubMed ID: 8666777
[TBL] [Abstract][Full Text] [Related]
10. Rejection of skin allografts by CD4+ T cells is antigen-specific and requires expression of target alloantigen on Ia- epidermal cells.
Rosenberg AS; Katz SI; Singer A
J Immunol; 1989 Oct; 143(8):2452-6. PubMed ID: 2477443
[TBL] [Abstract][Full Text] [Related]
11. Tolerance induction of allo-class II H-2 antigen-reactive L3T4+ helper T cells and prolonged survival of the corresponding class II H-2-disparate skin graft.
Hori S; Sato S; Kitagawa S; Azuma T; Kokudo S; Hamaoka T; Fujiwara H
J Immunol; 1989 Sep; 143(5):1447-52. PubMed ID: 2527264
[TBL] [Abstract][Full Text] [Related]
12. Mixed allogeneic reconstitution (A+B----A) to induce donor-specific transplantation tolerance. Permanent acceptance of a simultaneous donor skin graft.
Ildstad ST; Wren SM; Oh E; Hronakes ML
Transplantation; 1991 Jun; 51(6):1262-7. PubMed ID: 1828637
[TBL] [Abstract][Full Text] [Related]
13. Presentation of antigen to suppressor cells by a dimethylbenz (a) anthracene-resistant, Ia-positive, Thy-1-negative, I-J-restricted epidermal cell.
Halliday GM; Wood RC; Muller HK
Immunology; 1990 Jan; 69(1):97-103. PubMed ID: 1968886
[TBL] [Abstract][Full Text] [Related]
14. Induction of tolerance via skin depleted of Langerhans cells by a chemical carcinogen.
Halliday GM; Muller HK
Cell Immunol; 1986 Apr; 99(1):220-7. PubMed ID: 2944623
[TBL] [Abstract][Full Text] [Related]
15. Impact of donor MHC class I or class II antigen deficiency on first- and second-set rejection of mouse heart or liver allografts.
Qian S; Fu F; Li Y; Lu L; Rao AS; Starzl TE; Thomson AW; Fung JJ
Immunology; 1996 May; 88(1):124-9. PubMed ID: 8707337
[TBL] [Abstract][Full Text] [Related]
16. Presensitization by skin grafting from major histocompatibility complex class I or major histocompatibility complex class II deficient mice identifies class I antigens as inducers of allosensitization.
Qian S; Fu F; Li Y; Gao L; Lu L; Noyola H; Rao AS; Thomson AW; Fung JJ
Immunology; 1995 May; 85(1):82-7. PubMed ID: 7635525
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of the rejection of major histocompatibility complex class I-disparate murine skin grafts: rejection can be mediated by CD4+ cells activated by allo-class I + II antigen in CD8+ cell-depleted hosts.
Kobayashi E; Kawai K; Ikarashi Y; Fujiwara M
J Exp Med; 1992 Aug; 176(2):617-21. PubMed ID: 1354244
[TBL] [Abstract][Full Text] [Related]
18. IL-4 deficiency prevents eosinophilic rejection and uncovers a role for neutrophils in the rejection of MHC class II disparate skin grafts.
Surquin M; Le Moine A; Flamand V; Rombaut K; Demoor FX; Salmon I; Goldman M; Abramowicz D
Transplantation; 2005 Nov; 80(10):1485-92. PubMed ID: 16340795
[TBL] [Abstract][Full Text] [Related]
19. MHC class I and II antigens as targets of rejection in penetrating keratoplasty in low- and high-risk mouse eyes.
Osawa H; Streilein JW
Cornea; 2005 Apr; 24(3):312-8. PubMed ID: 15778605
[TBL] [Abstract][Full Text] [Related]
20. Prevention and restoration of second-set liver allograft rejection in presensitized mice: the role of "passenger" leukocytes, donor major histocompatibility complex antigens, and host cytotoxic effector mechanisms.
Fu F; Li W; Lu L; Thomson AW; Fung JJ; Qian S
Transplantation; 1999 Feb; 67(3):444-50. PubMed ID: 10030293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
